Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPOR | P19235 | 3/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | MC4R | P32245 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30605860 | 0.93 | EPOR (0.42) | EPORHTR2AMC4RALDH1A1SMN1; SMN2 | |
| SCHEMBL10432184 | 0.89 | MC4R (0.47) | EPORMC4RRAB9ANPC1SSTR3 | |
| SCHEMBL11054264 | 0.83 | MAPT (0.50) | EPORHTR2AMC4RRAB9ANPC1 | |
| SCHEMBL11182740 | 0.82 | MAPT (0.51) | HTR2AMC4RRAB9ANPC1SSTR3 | |
| SCHEMBL7959193 | 0.82 | GAA (0.43) | HTR2AALDH1A1SMN1; SMN2LMNAGAA | |
| SCHEMBL4391556 | 0.82 | GAA (0.43) | HTR2AALDH1A1SMN1; SMN2LMNAGAA | |
| SCHEMBL16494584 | 0.80 | HDAC1 (0.55) | SSTR3HDAC1HDAC2 | |
| SCHEMBL648254 | 0.80 | HDAC1 (0.55) | SSTR3HDAC1HDAC2 | |
| SCHEMBL27584149 | 0.80 | EPOR (0.48) | EPORLTA4H | |
| Hydrochloric Acid SCHEMBL28627653 | 0.79 | HDAC1 (0.54) | SSTR3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194063-B1 | Production and use of modified polylysines | BASF SE (DE) | 2014-01-08 | — | — | EP | disclosed |
| EP-2111236-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-10-28 | — | — | EP | disclosed |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | EPIX PHARMACEUTICALS, INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008087017-A2 | NOVEL CASCADE POLYMER COMPLEXES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THE SAME | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-24 | — | — | WO | disclosed |
| US-7211241-B2 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | SCHERING AKTIENGESELLSCHAFT (DE) | 2007-05-01 | — | — | US | disclosed |
| US-6861043-B2 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | SCHERING AG (DE) | 2005-03-01 | — | — | US | disclosed |
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-05-13 | — | — | US | disclosed |
| EP-0946525-B1 | METHOD FOR PRODUCING METAL COMPLEX CARBOXYLIC ACID AMIDES | SCHERING AG (DE) | 2004-04-07 | — | — | EP | disclosed |
| EP-0946526-B1 | MACROCYCLIC METAL COMPLEX CARBOXYLIC ACIDS, USE AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AG (DE) | 2003-10-29 | — | — | EP | disclosed |
| EP-0768898-B1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AG (DE) | 2003-04-09 | — | — | EP | disclosed |
| EP-0868202-A1 | CASCADE POLYMER COMPLEXES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICALS CONTAINING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-10-07 | — | — | EP | disclosed |
| WO-1998024774-A1 | MACROCYCLIC METAL COMPLEX CARBOXYLIC ACIDS, USE AND METHOD FOR THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-06-11 | — | — | WO | disclosed |
| WO-1998024775-A1 | METHOD FOR PRODUCING METAL COMPLEX CARBOXYLIC ACID AMIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-06-11 | — | — | WO | disclosed |
| EP-0836485-A2 | CASCADE POLYMER COMPLEXES | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-22 | — | — | EP | disclosed |
| EP-0832150-A1 | CASCADE POLYMERS WITH IODINE-CONTAINING AROMATIC COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997023245-A1 | CASCADE POLYMER COMPLEXES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICALS CONTAINING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-07-03 | — | — | WO | disclosed |
| EP-0768898-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-23 | — | — | EP | disclosed |
| WO-1997002051-A2 | CASCADE POLYMER COMPLEXES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-01-23 | — | — | WO | disclosed |
| WO-1996041830-A1 | CASCADE POLYMERS WITH IODINE-CONTAINING AROMATIC COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-12-27 | — | — | WO | disclosed |
| WO-1996001655-A1 | CASCADE-POLYMER COMPLEXES AND METHODS OF PRODUCING THE SAME | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | ZYX, CCNY, MOK | EPOR 1015/4885HTR2A 3043/4885MC4R 2973/4885 |
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PGF, F13A1, F11 | EPOR 970/4885HTR2A 2892/4885MC4R 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.